Passer au contenu
OTR3, Science for Regeneration
  • Qui sommes-nous ?
  • Notre technologie
    • Technologie des RGTA®
    • Pipeline
    • Publications
  • Nos engagements
  • Notre activité commerciale
    • Dispositif médical pour l’homme
      • Cacipliq 20®
    • Produits vétérinaires
      • Clerapliq®
      • Dermapliq® Spray
    • Cosmétique Sportive
  • Actualités
  • Contact
  • Français
    • Français
    • English

RGTA technology

  • June 2025 – Lecture and Post from two OTR3 members at GSMM congress 10-12 of June 2025

    News | RGTA technology

    Lecture from Aubert de Lichy Structure resolution of glucose units in a heparan sulfate mimetic (RGTA®) fragment by NMR and molecular dynamics simulations Abstract: ReGeneraTing Agents (RGTA®) are synthetic polysaccharides designed to mimic the structural and functional properties of heparan sulfates (HS), essential components of the extracellular matrix that are [...]

  • Overview of 10 years of practice with CACIPLIQ20® matrix therapy as a healing agent for hard to heal wounds: Efficacy, cost-effectiveness and future perspectives

    Cacipliq 20 | Media Publications | RGTA technology

    Overview of 10 years of practice with CACIPLIQ20® matrix therapy as a healing agent for hard to heal wounds: Efficacy, cost-effectiveness and future perspectives Background: Chronic, non-healing wounds remain a major challenge for health care practitioners and for society in general, both in terms of the enormous economic burden [...]

OTR3, Science for Regeneration

Organes Tissus Régénération Réparation Remplacement

©2025 | OTR3 | All rights reserved.

  • Politique de confidentialité
  • Mentions légales
Kiwik, agence web à Orléans
Page load link
Aller en haut